Clinical Trials Logo

Clinical Trial Summary

Antimicrobial resistance is one of the greatest threats to human health, and is driven by inappropriate antimicrobial use. Antimicrobial stewardship programs (ASPs) improve the use of antimicrobials in hospitals. The purpose of this study is to identify the need for and barriers to implementation of ASPs in three hospitals in Sri Lanka, Kenya, and Tanzania.


Clinical Trial Description

Antimicrobial resistance is one of the greatest threats to human health, and is driven by the inappropriate antimicrobial use. Antimicrobial stewardship programs (ASPs) improve the use of antimicrobials. The purpose of this study is to identify the need for and barriers to implementation of ASPs in three hospitals in Sri Lanka, Kenya, and Tanzania. The impact of creating a basic ASP will be assessed at each hospital. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03382470
Study type Observational
Source Duke University
Contact
Status Completed
Phase
Start date March 12, 2018
Completion date March 8, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT06313619 - Decreasing Irrational Antimicrobial Use in Bangladesh: A Digital Intervention Program N/A
Completed NCT03676751 - MORDOR II Burkina Faso: Longitudinal Trial Phase 4
Recruiting NCT04224987 - Azithromycin for Child Survival in Niger: Mortality and Resistance Trial Phase 4
Active, not recruiting NCT04567368 - TB-CAPT MTB/XDR Study
Not yet recruiting NCT04652284 - Effectiveness of Rifabutin for Treatment of Helicobacter Pylori Phase 3
Completed NCT03477084 - Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities
Recruiting NCT06322173 - Molecular Diagnostics of Bacterial Infections and Antibiotic Resistance in Blood Samples and Rectal Swabs Using Advanced NGS Sequencing Methods N/A
Active, not recruiting NCT05231187 - T2Resistance - Detection of Resistance Related Genes
Recruiting NCT03863249 - Use of the xCELLigence System for Quantification of Bacterial Biofilm's Real Time Formation and Antibiotics Selection. Phase 4
Recruiting NCT04188743 - Decolonization of Gram-negative Multi-resistant Organisms (MDRO) With Donor Microbiota (FMT) Phase 2/Phase 3
Recruiting NCT05288023 - Azithromycin for Child Survival in Niger: Programmatic Trial (AVENIR) Phase 4
Completed NCT03937245 - Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care